help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 9, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-2506
A more recent version of this article appeared on August 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/8/2833    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oliva-Hemker, M
Right arrow Articles by Yardley, J H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oliva-Hemker, M
Right arrow Articles by Yardley, J H
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Nutrition

Submitted on November 21, 2005
Accepted on May 2, 2006

Pernicious Anemia and Widespread Absence of Gastrointestinal Endocrine Cells in a Patient with Autoimmune Polyglandular Syndrome Type I (APS I) and Malabsorption

M Oliva-Hemker, G V Berkenblit, G J Anhalt, and J H Yardley*

The authors are associated with the Departments of Pediatrics (MO-H), Medicine (GVB), Dermatology (GJA), and Pathology (JHY) at the Johns Hopkins University School of Medicine and Hospital in Baltimore, MD

* To whom correspondence should be addressed. E-mail: jyardley{at}jhmi.edu.

Context: Autoimmune polyglandular syndrome type I (APS I) is characterized by multiple endocrine gland failures, with other manifestations such as gastrointestinal (GI) symptoms.

Objective: To study the histopathologic and immunologic findings in the GI mucosa of a patients with typical features of APS I, malabsorption and pernicious anemia.

Design and Patient: Biopsies from the GI tract of a patient with APS I were immunostained with chromogranin for GI endocrine cells (GIECs). Blinded slides were graded for numbers of endocrine cells. Normal gastric mucosa was exposed to the patient's serum to test for circulating anti-GIEC and anti-parietal cell antibodies using indirect immunofluorescence.

Setting: Departments of Pediatric and Medical Gastroenterology in an academic medical center.

Results: The patient's GI mucosa demonstrated absence of GIECs throughout, including gastric gastrin-secreting cells, and her laboratory tests for serum gastrin levels were low normal. Both GIECs and parietal cells were absent in her gastric corpus. The patient's serum contained anti-GIEC antibody but no anti-parietal cell antibody.

Conclusions: These observations suggest that GIECs in APS I are subject to an autoimmune destruction that can cause widespread GIEC loss. This could explain the GI dysfunctions that are often noted in the syndrome including malabsorption and atrophic gastric changes with pernicious anemia. We also hypothesize that absence of gastric parietal cells may result mainly from hypogastrinemia that is mainly the loss of gastrin-secreting cells rather than from immune-mediated destruction of parietal cells like that seen in the atrophic gastritis associated with adult-onset pernicious anemia.


Key words: Autoimmune Polyglandular Syndrome Type I • Gastrointestinal Endocrine Cells • Pernicious anemia • Malabsorption







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society